H2 2026 Earnings
Financial report interval: 2025.12.30 - 2026.06.30
Overview: Mesoblast(MESO) the Revenue is 66.24 M (+371.8%), Miss estimate;the EBIT is -19.52 M (+53.46%), Miss estimate;the EPS is -0.133 (+37.56%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.07B371.76%
0.07B420.65%
-0.01B48.89%
EBITMiss expectations
-0.02B53.46%
-0.01B85.30%
-0.01B31.84%
EPSExceed expectations
-0.13337.56%
-0.1529.58%
+0.01707.98%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf